The present invention relates to a method of suppressing bone marrow and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid. The peripheral wall of the nozzle has at least one cut-out through which the wire-guide system passes. The controller receives an instruction for allocating an initialized real storage resource to a first virtual storage resource accessed by the host computer. Also, when an electric power consumption in a vehicle is equal to or greater than a predetermined value, the combustion mode maintaining operation is cancelled, and the power generation quantity of the power generator is controlled in a manner that does not cause overdischarge of the battery.